Anton Y. Peleg, MBBS PhD MPH FRACP
Anton Y. Peleg, MBBS PhD MPH FRACP
Alfred Hospital and Monash University
Verified email at monash.edu
Title
Cited by
Cited by
Year
Acinetobacter baumannii: emergence of a successful pathogen
AY Peleg, H Seifert, DL Paterson
Clinical microbiology reviews 21 (3), 538-582, 2008
35182008
Hospital-acquired infections due to gram-negative bacteria
AY Peleg, DC Hooper
New England Journal of Medicine 362 (19), 1804-1813, 2010
14512010
Common infections in diabetes: pathogenesis, management and relationship to glycaemic control
AY Peleg, T Weerarathna, JS McCarthy, TME Davis
Diabetes/metabolism research and reviews 23 (1), 3-13, 2007
4992007
Treatment of Acinetobacter Infections
J Fishbain, AY Peleg
Clinical infectious diseases 51 (1), 79-84, 2010
4302010
Medically important bacterial–fungal interactions
AY Peleg, DA Hogan, E Mylonakis
Nature reviews microbiology 8 (5), 340-349, 2010
4262010
Risk Factors, Clinical Characteristics, and Outcome of Nocardia Infection in Organ Transplant Recipients: A Matched Case-Control Study
AY Peleg, S Husain, ZA Qureshi, FP Silveira, M Sarumi, KA Shutt, ...
Clinical Infectious Diseases 44 (10), 1307-1314, 2007
3522007
Acinetobacter baumannii bloodstream infection while receiving tigecycline: a cautionary report
AY Peleg, BA Potoski, R Rea, J Adams, J Sethi, B Capitano, S Husain, ...
Journal of Antimicrobial Chemotherapy 59 (1), 128-131, 2007
3222007
Phenotypic detection of carbapenem-susceptible metallo-β-lactamase-producing gram-negative bacilli in the clinical laboratory
C Franklin, L Liolios, AY Peleg
Journal of clinical microbiology 44 (9), 3139-3144, 2006
3142006
Tigecycline efflux as a mechanism for nonsusceptibility in Acinetobacter baumannii
AY Peleg, J Adams, DL Paterson
Antimicrobial agents and chemotherapy 51 (6), 2065-2069, 2007
3062007
Galleria mellonella as a model system to study Acinetobacter baumannii pathogenesis and therapeutics
AY Peleg, S Jara, D Monga, GM Eliopoulos, RC Moellering, E Mylonakis
Antimicrobial agents and chemotherapy 53 (6), 2605-2609, 2009
2642009
Effect of piperacillin-tazobactam vs meropenem on 30-day mortality for patients with E coli or Klebsiella pneumoniae bloodstream infection and ceftriaxone resistance: a …
PNA Harris, PA Tambyah, DC Lye, Y Mo, TH Lee, M Yilmaz, TH Alenazi, ...
Jama 320 (10), 984-994, 2018
2572018
Opportunistic infections in 547 organ transplant recipients receiving alemtuzumab, a humanized monoclonal CD-52 antibody
AY Peleg, S Husain, EJ Kwak, FP Silveira, M Ndirangu, J Tran, KA Shutt, ...
Clinical Infectious Diseases 44 (2), 204-212, 2007
2492007
Management of meningitis due to antibiotic-resistant Acinetobacter species
BN Kim, AY Peleg, TP Lodise, J Lipman, J Li, R Nation, DL Paterson
The Lancet infectious diseases 9 (4), 245-255, 2009
2362009
Dissemination of the Metallo-β-Lactamase Gene blaIMP-4 among Gram-Negative Pathogens in a Clinical Setting in Australia
AY Peleg, C Franklin, JM Bell, DW Spelman
Clinical Infectious Diseases 41 (11), 1549-1556, 2005
2302005
Acinetobacter baumannii: evolution of antimicrobial resistance—treatment options
Y Doi, GL Murray, AY Peleg
Seminars in respiratory and critical care medicine 36 (1), 85, 2015
2062015
Candida albicans hyphal formation and virulence assessed using a Caenorhabditis elegans infection model
R Pukkila-Worley, AY Peleg, E Tampakakis, E Mylonakis
Eukaryotic cell 8 (11), 1750-1758, 2009
1822009
Whole genome characterization of the mechanisms of daptomycin resistance in clinical and laboratory derived isolates of Staphylococcus aureus
AY Peleg, S Miyakis, DV Ward, AM Earl, A Rubio, DR Cameron, S Pillai, ...
PloS one 7 (1), e28316, 2012
1792012
Prokaryote–eukaryote interactions identified by using Caenorhabditis elegans
AY Peleg, E Tampakakis, BB Fuchs, GM Eliopoulos, RC Moellering, ...
Proceedings of the National Academy of Sciences 105 (38), 14585-14590, 2008
1672008
Carbapenem resistance in Acinetobacter baumannii: laboratory challenges, mechanistic insights and therapeutic strategies
I Abbott, GM Cerqueira, S Bhuiyan, AY Peleg
Expert review of anti-infective therapy 11 (4), 395-409, 2013
1642013
Reduced Susceptibility to vancomycin influences pathogenicity in Staphylococcus aureus infection
AY Peleg, D Monga, S Pillai, E Mylonakis, RC Moellering Jr, ...
The Journal of infectious diseases 199 (4), 532-536, 2009
1612009
The system can't perform the operation now. Try again later.
Articles 1–20